Focused Wealth Management, Inc Global Blood Therapeutics, Inc. Transaction History

Focused Wealth Management, Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 19, 2020	SELL	$52.76 - $74.49 $42,208 - $59,591	-800 Closed	0 $0
Q2 2020 Jul 24, 2020	SELL	$48.73 - $81.82 $18,273 - $30,682	-375 Reduced 31.91%	800 $51,000
Q1 2020 May 06, 2020	SELL	$41.72 - $87.2 $417 - $872	-10 Reduced 0.84%	1,175 $60,000
Q4 2019 Jan 21, 2020	SELL	$45.7 - $81.86 $103,053 - $184,594	-2,255 Reduced 65.55%	1,185 $94,000
Q3 2019 Nov 06, 2019	BUY	$45.35 - $57.91 $13,605 - $17,373	300 Added 9.55%	3,440 $167,000
Q4 2018 Jan 30, 2019	BUY	$31.54 - $46.67 $12,616 - $18,668	400 Added 14.6%	3,140 $129,000
Q3 2018 Nov 13, 2018	BUY	$38.0 - $51.1 $104,120 - $140,014	2,740 New	2,740 $104,000
Q1 2018 May 07, 2018	SELL	$39.6 - $65.9 $253,440 - $421,760	-6,400 Closed	0 $0
Q4 2017 Feb 13, 2018	BUY	$29.7 - $45.7 $190,080 - $292,480	6,400	6,400 $252,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Focused Wealth Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Focused Wealth Management, Inc with notifications on news.